TNF AND IL-1 GENERATION BY HUMAN MONOCYTES IN RESPONSE TO BIOMATERIALS

被引:78
作者
CARDONA, MA
SIMMONS, RL
KAPLAN, SS
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA 15261
[2] UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 1992年 / 26卷 / 07期
关键词
D O I
10.1002/jbm.820260703
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The biocompatibility of surgically implanted materials may be compromised as a consequence of inflammatory reactions associated with phagocyte activation. Two important mediators of the inflammatory response are Interleukin-1 (IL-1) and tumor necrosis factor (TNF), both of which exert a wide range of biologic effects on many cells. This study was designed to evaluate the release of these cytokines by human monocytes (HM) brought into contact with four biomaterials utilized in clinical practice: polyurethane, expanded polytetrafluorethylene (ePTFE), Dacron velour, and woven Dacron. In vitro cultures for the generation of IL-1 and TNF by HM in the presence of the above biomaterials were established by exposing cells to each biomaterial in the presence and absence of lipopolysaccharide (LPS) with harvest of supernatants after 6 or 18 h. These studies showed that in the absence of LPS, IL-1 was released only by Dacron velour and woven Dacron associated monocytes while TNF was secreted in response to all of the materials. When LPS was present, however, monocytes associated with all of the materials released IL-1; and TNF release was greatly augmented. Further, the quantity of released cytokine was directly related to the duration of the association time. This study demonstrated that HM in association with various biomaterials were activated to produce both TNF and IL-1 and that the addition of nanogram quantities of LPS, such as would be produced if infection were present, greatly increased the amount of cytokines released.
引用
收藏
页码:851 / 859
页数:9
相关论文
共 34 条
[11]   MACROPHAGE FIBRINOLYTIC-ACTIVITY - IDENTIFICATION OF 2 PATHWAYS OF PLASMIN FORMATION BY INTACT-CELLS AND OF A PLASMINOGEN-ACTIVATOR INHIBITOR [J].
CHAPMAN, HA ;
VAVRIN, Z ;
HIBBS, JB .
CELL, 1982, 28 (03) :653-662
[12]  
DECKER T, 1987, J IMMUNOL, V138, P957
[13]   TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1 [J].
DINARELLO, CA ;
CANNON, JG ;
WOLFF, SM ;
BERNHEIM, HA ;
BEUTLER, B ;
CERAMI, A ;
FIGARI, IS ;
PALLADINO, MA ;
OCONNOR, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1433-1450
[14]   RELEASE OF TUMOR NECROSIS FACTOR-ALPHA BY HUMAN PERITONEAL-MACROPHAGES INVIVO AND INVITRO [J].
HALME, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) :1718-1725
[15]  
HAMISH R, 1988, NEW ENGL J MED, V318, P1481
[16]  
HENSON PM, 1980, AM J PATHOL, V101, P494
[17]   A FLOW CYTOMETRIC AND IMMUNOFLUORESCENCE MICROSCOPIC STUDY OF TUMOR NECROSIS FACTOR PRODUCTION AND LOCALIZATION IN HUMAN-MONOCYTES [J].
HOFSLI, E ;
BAKKE, O ;
NONSTAD, U ;
ESPEVIK, T .
CELLULAR IMMUNOLOGY, 1989, 122 (02) :405-415
[18]  
IWAMOTO G, 1989, AM J PHYSIOL, V132, pC1012
[19]  
KAPLAN SS, IN PRESS J BIOMED MA
[20]  
KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220